For those of us who thought that Roche vs CIPLA dispute concerning Erlotinib Hydrochloride was over following from the findings by the Division Bench, here is an update –  CIPLA has now filed a SLP before the Supreme Court of India.

Stay tuned for more updates on this segment.


Discover more from Patents Rewind – An Anand and Anand Blog

Subscribe to get the latest posts sent to your email.

One response to “The battle continues…”

  1. SC allows Cipla to withdraw its petition | PatentsRewind Avatar

    […] petition was filed by Cipla challenging the High Court’s order holding that it had infringed Roche’s patent. The two companies, Roche and Cipla, on May […]

    Like

Leave a Reply